Inhibition of Th1 development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1,25-dihydroxyvitamin D3

European Journal of Immunology

Volumn 30, Issue 2, 2000, Pages 498-508

  Mattner, Frank ^a   Smiroldo, Simona ^a   Galbiati, Francesca ^a   Muller, Marc ^b   Di Lucia, Pietro ^a   Poliani, Pietro L ^c   Martino, Gianvito ^c   Panina Bordignon, Paola ^a   Adorini, Luciano ^a  

^a ROCHE MILANO RICERCHE   (Italy)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

^c SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Chronic relapsing experimentall allergic encephalomyelitis; Th1; Vitamin D3

Indexed keywords

CALCITRIOL; CALCITRIOL DERIVATIVE; CALCIUM; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 4; MYELIN ASSOCIATED GLYCOPROTEIN; PEPTIDE; RO 63 2023; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; TH1 CELL;

ANIMALS; CALCITRIOL; CALCIUM CHANNEL AGONISTS; CELL DIFFERENTIATION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; IMMUNITY, CELLULAR; MICE; MICE, INBRED C57BL; MYELIN-ASSOCIATED GLYCOPROTEIN; TH1 CELLS; TH2 CELLS;

EID: 0033975024     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200002)30:2<498::AID-IMMU498>3.0.CO;2-Q     Document Type: Article

References (55)

1. Abbas, A. K., Murphy, K. M. and Sher, A., Functional diversity of helper T lymphocytes. Nature 1997. 383: 787-793.
2. Gately, M. K., Renzetti, L. M., Magram, J., Stern, A. S., Adorini, L., Gubler, U. and Presky, D. H., The interleukin-12/ interleukin-12-receptor system: role in normal and pathologic immune responses. Annu. Rev. Immunol. 1998. 16: 495-512.
3. Paul, W. E. and Seder, R. A., Lymphocytes responses and cytokines. Cell 1994. 76: 241-251.
4. Trembleau, S., Penna, G., Bosi, E., Mortara, A., Gately, M. K. and Adorini, L., IL-12 administration induces Th1 cells and accelerates autoimmune diabetes in NOD mice. J. Exp. Med. 1995. 181: 817-821.
5. Leonard, J. P., Waldburger, K. E. and Goldman, S. J., Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin-12. J. Exp. Med. 1995. 181: 381-386.
6. Germann, T., Szeliga, J., Hess, H., Stoerkel, S., Podlaski, F. J. and Gately, M. K., Schmitt, E. and Ruede, E., Administration of IL-12 in combination with type II collagen induces severe arthritis in DBA/1 mice. Proc. Natl. Acad. Sci. USA 1995. 92: 4823-4827.
7. Xu, H., Rizzo, L. V., Silver, P. B. and Caspi, R. R., Uveitogenicity is associated with a Th1-like lymphokine profile: cytokine-dependent modulation of early and committed effector T cells in experimental autoimmune uveitis. Cell. Immunol. 1997. 178: 69-78.
8. Neurath, M. F., Fuss, I., Kelsall, B. L., Stueber, E. and Strober, W., Antibodies to interleukin 12 abrogate established experimental colitis in mice. J. Exp. Med. 1995. 182: 1281-1290.
9. Moiola, L., Galbiati, F., Martino, G., Amadio, S., Brambilla, E., Comi, G., Grimaldi, L. M. E. and Adorini, L., IL-12 is involved in the induction of experimental autoimmune myasthenia gravis, an antibody-mediated disease. Eur. J. Immunol. 1998. 28: 2487-2497.
10. Trembleau, S., Penna, G., Gregori, S., Gately, M. K. and Adorini, L., Deviation of pancreas-infiltrating cells to Th2 by interleukin-12 antagonist administration inhibits autoimmune diabetes. Eur. J. Immunol. 1997. 27: 2230-2239.
11. 2. Diabetologia 1997. 40: 641-646.
12. Constantinescu, C. S., Wysocka, M., Hilliard, B., Ventura, E., Lavi, E., Trinchieri, G. and Rostami, A., Antibodies against interleukin-12 prevent superantigen-induced and spontaneous relapses of experimental allergic encephalomyelitis. J. Immunol. 1998. 161: 5097-5104.
13. Comabella, M., Balashov, K., Issazadeh, S., Smith, D., Weiner, H. L. and Khoury, S. J., Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy. J. clin. Invest. 1998. 102: 671-678.
14. Rott, O., Evelyne, C. and Fleischer, B., Phosphodiesterase inhibitor pentoxifylline, a selective suppressor of T helper type 1-but not type 2-associated lymphokine production, prevents induction of experimental autoimmune encephalomyelitis in Lewis rats. Eur. J. Immunol. 1993. 23: 1745-1751.
15. Bright, J. J., Du, C., Coon, M., Sriram, S. and Klaus, S. J., Prevention of experimental allergic encephalomyelitis via inhibition of IL-12 signaling and IL-12-mediated Th1 differentiation: an effect of the novel anti-inflammatory drug lisofylline. J. Immunol. 1998. 161: 7015-7022.
16. Van der Pouw Kraan, T. C. T. M., Boeije, L. C. M., Smeenk, R. J. T., Wijdenes, J. and Aarden, L. A., Prostaglandin-E2 is a potent inhibitor of human interleukin 12 prouction. J. Exp. Med. 1995. 181: 775-779.
17. 2-Agonists prevent Th1 development by selective inhibition of interleukin 12. J. Clin. Invest. 1997. 100: 1513-1519.
18. Aloisi, F., Penna, G., Cerase, J., Menéndez Iglesias, B. and Adorini, L., IL-12 production by central nervous system microglia is inhibited by astrocytes. J. Immunol. 1997. 159: 1604-1612.
19. + lymphocytes by inhibiting IL-12 production. J. Immunol. 1998. 160: 2231-2237.
20. 3: preferential inhibition of Th1 functions. J. Nutrition 1995. 125: 1704S-1708S.
21. 3. J. Clin. Invest. 1998. 101: 252-262.
22. 3. Curr. Opin. Nephrol. Hypertens. 1995. 4: 313-318.
23. 3 administration on lymphoproliferation and autoimmune disease in MRL/MP Ipr/Ipr mice. Int. Arch. Allergy Appl. Immunol. 1985. 77: 396-404.
24. Lemire, J. M. and Archer, C., 1,25-Dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. J. Clin. Invest. 1991. 87: 1103-1107.
25. 3. J. Neuroimmunol. 1995. 61: 151-160.
26. 3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc. Natl. Acad. Sci. USA 1996. 93: 7861-7864.
27. 3. Diabetologia 1994. 37: 552-558.
28. Santambrogio, L., Crisi, G. M., Leu, J., Hochwald, G. M., Ryan, T. and Thorbecke, G. J., Tolerogenic forms of auto-antigens and cytokines in the induction of resistance to experimental allergic encephalomyelitis. J. Neuroimmunol. 1995. 58: 211-222.
29. Segal, B. M., Dwyer, B. K. and Shevach, E. M., An interleukin (IL)-10/IL-12 irnmunoregulatory circuit controls susceptibility to autoimmune disease. J. Exp. Med. 1998. 187: 537-546.
30. Issazadeh, S., Ljungdahl, A., Hoejeberg, B., Mustafa, M. and Olsson, T., Cytokine production in the central nervous system of Lewis rats with experimental autoimmune encephalomyelitis: dynamics of mRNA expression for inteleukin-10, interleukin-12, tumor necrosis factor α and tumor necrosis factor β. J. Neuroimmunol. 1995. 61: 205-212.
31. Martin, R., McFarland, H. F. and McFarlin, D. E., Immunological aspects of demyelinating diseases. Annu. Rev. Immunol. 1992. 10: 153-187.
32. Trembleau, S., Germann, T., Gately, M. K. and Adorini, L., The role of IL-12 in the induction of organ-specific autoimmune diseases. Immunol. Today 1995. 16: 383-386.
33. Brod, S. A., Benjamin, D. and Hafler, D. A., Restricted T cell expression of IL-2, IFN-γ mRNA in human inflammatory disease. J. Immunol. 1991. 147: 810-815.
34. Windhagen, A., Newcombe, J., Dangond, F., Strand, C., Woodroofe, M. N., Cuzner, M. L. and Hafler, D. A., Expression of costimulatory molecules B7-1 (CD80) and B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions. J. Exp. Med. 1995. 182: 1985-1996.
35. Nicoletti, F., Patti, F., Cocuzza, C., Zaccone, P., Nicoletti, A., Di Marco, R. and Reggio, A., Elevated serum levels of interleukin-12 in chronic progressive multiple sclerosis. J. Neuroimmunol. 1996. 70: 87-90.
36. + T cells via CD40 ligand. Proc. Natl. Acad. Sci. USA 1997. 94: 599-603.
37. Correale, J., McMillan, M., Li, S., McCarthy, L., Le, T. and Weiner, L., Antigen presentation by autoreactive proteolipid protein-specific T cell clones from progressive multiple sclerosis patients: roles of co-stimulatory B7 molecules and IL-12. J. Neuroimmunol. 1997. 72: 27-43.
38. 3 is a positive regulator for the two anti-encephalitogenic cytokines TGF-β1 and IL-4. J. Immunol. 1998. 160: 5314-5319.
39. Packe, M., Dhib-Jalbut, S., Cannella, B., Alert, P., Raine, C. and McFarlin, D., Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-β1. J. Immunol. 1991. 146: 3012-3019.
40. Racke, M. K., Bonomo, A., Scott, D. E., Cannella, B., Levine, A., Raine, C. S., Shevach, E. M. and Roecken, M., Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J. Exp. Med. 1994. 180: 1961-1966.
41. Furlan, R., Poliani, P. L., Galbiati, F., Bergami, A., Grimaldi, L., Comi, G., Adorini, L. and Martino, G., Central nervous system delivery of interleukin 4 by a nonreplicative herpes simplex type 1 viral vector ameliorates autoimmune demyelination. Hum. Gene Ther. 1998. 9: 2605-2617.
42. Bettelli, E., Prabhu Das, M., Howard, E. D., Weiner, H. L., Sobel, R. A. and Kuchroo, V. K., IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10 and IL-4-deficient and transgenic mice. J. Immunol. 1998. 161: 3299-3306.
43. Clavreul, A., D'Hellencourt, C., Montero-Menel, C., Potron, G. and Couez, D., Vitamin D differentially regulates B7.1 and B7.2 expression on human peripheral blood monocytes. Immunology 1998. 95: 272-277.
44. Garcion, E., Nataf, S., Berod, A., Darcy, F. and Brachet, P., 1.25-Dihydroxyvitamin D3 inhibits the expression of inducible nitric oxide synthase in rat central nervous system during experimental allergic encephalomyelitis. Brain Res. 1997. 45: 255-267.
45. 3: direct inhibition NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol. Cell. Biol. 1995. 15: 5789-5799.
46. 3: a transcriptional modulator of the IFN-γ gene. Eur J. Immunol. 1998. 28: 3017-3030.
47. 3H]1,25-dihydroxyvitamin D3 uptake by canine and rodent brain. Am. J. Physiol. 1983. 244: 266-271.
48. Vanmaele, L, De Clercq, P. and Vandewalle, M., An efficient synthesis of 1,25 dihydroxy vitamin D3. Tetrahedron 1985. 41: 141-144.
49. Barbier, P., Bauer, F., Mohr, P., Muller, M. and Pirson, W., Polyinsaturated 24a, 24b dihomosecocholestane derivatives. WO99/03828 28. 1. 1999.
50. Recalde, H. R., A simple method of obtaining monocytes in suspension. J. Immunol. Methods 1984. 69: 71-77.
51. Gately, M. K., Chizzonite, R. and Presky, D. H., Measurement of human and mouse IL-12. in Coligan, J. E., Kruisbeek, A, M., Margulies, D. H., Shevach, E. M. and Strober, W. (Eds.) Current Protocols in Immunology, Wiley, New York 1995, Vol. 3, 15: 6.16.11-16.16.15.
52. Buck, C., Brundschu, J., Gallati, H. P. B. and Pohlandt, F., Interleukin-6: a sensitive parameter for the early diagnosis of neonatal bacterial infection. Pediatrics 1994. 93: 54-58.
53. Galbiati, F., Rogge, L., Guéry, J.-C., Smiroldo, S. and Adorini, L., Regulation of the interleukin (IL)-12 receptor β2 subunit by soluble antigen and IL-12 in vivo. Eur. J. Immunol. 1998. 28: 209-220.
54. Baker, D., O'Neill, J. K., Gschmeisser, S. E., Wilcox, S. E., Butter, C. and Turk, J. L., Induction of chronic-relapsing experimental allergic encephalomyelitis in Biozzi mice. J. Neuroimmunol. 1990. 28: 261-270.
55. Piddlesden, S. J., Storch, M. K., Hibbs, M., Freeman, A. M., Lassmann, H. and Morgan, B. P., Soluble recombinant complement receptor 1 inhibits inflammation and demyelination in antibody-mediated demyelinating experimental allergic encephalomyelitis. J. Immunol. 1994. 152: 5477-5484.